Home > Products > CD3 & IGF1R
> Anti-CD3 x Anti-IGF1R Bispecific Antibody (IgG-IgG)
Anti-CD3 x Anti-IGF1R Bispecific Antibody (IgG-IgG) (CAT#: BSIG-092)
Anti-CD3 x Anti-IGF1R Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD3 and anti-IGF1R parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Melanoma; Colon cancer; Pancreas cancer; Prostate cancer; Kidney cancer therapy.
There are currently no customer reviews or questions for Anti-CD3 x Anti-IGF1R Bispecific Antibody (IgG-IgG) (BSIG-092). Click the button below to contact us or submit your feedback about this product.